Canandaigua National Bank & Trust’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $9.01M | Buy |
+7,511
| New | +$7.67M | 0.76% | 28 |
|
|
2025
Q4 | $9.36M | Sell |
8,708
-284
| -3% | -$272K | 0.84% | 25 |
|
|
2025
Q3 | $6.86M | Buy |
8,992
+833
| +10% | +$620K | 0.6% | 34 |
|
|
2025
Q2 | $6.36M | Buy |
8,159
+909
| +13% | +$706K | 0.59% | 37 |
|
|
2025
Q1 | $5.99M | Buy |
7,250
+232
| +3% | +$193K | 0.6% | 37 |
|
|
2024
Q4 | $5.42M | Sell |
7,018
-1,314
| -16% | -$1.09M | 0.53% | 40 |
|
|
2024
Q3 | $7.38M | Buy |
8,332
+1,620
| +24% | +$1.46M | 0.7% | 34 |
|
|
2024
Q2 | $6.08M | Sell |
6,712
-61
| -0.9% | -$48.8K | 0.66% | 32 |
|
|
2024
Q1 | $5.27M | Sell |
6,773
-207
| -3% | -$147K | 0.78% | 33 |
|
|
2023
Q4 | $4.07M | Sell |
6,980
-181
| -3% | -$106K | 0.63% | 42 |
|
|
2023
Q3 | $3.85M | Buy |
7,161
+765
| +12% | +$394K | 0.62% | 41 |
|
|
2023
Q2 | $3M | Sell |
6,396
-79
| -1% | -$33.1K | 0.49% | 58 |
|
|
2023
Q1 | $2.22M | Buy |
+6,475
| New | +$2.18M | 0.37% | 77 |
|
|
2020
Q1 | $1.72M | Sell |
12,368
-632
| -5% | -$86.8K | 0.36% | 76 |
|
|
2019
Q4 | $1.71M | Sell |
13,000
-1,304
| -9% | -$151K | 0.29% | 93 |
|
|
2019
Q3 | $1.6M | Buy |
14,304
+1,990
| +16% | +$222K | 0.28% | 94 |
|
|
2019
Q2 | $1.36M | Sell |
12,314
-390
| -3% | -$45.9K | 0.25% | 103 |
|
|
2019
Q1 | $1.65M | Buy |
12,704
+1,068
| +9% | +$130K | 0.32% | 93 |
|
|
2018
Q4 | $1.35M | Sell |
11,636
-1,269
| -10% | -$142K | 0.28% | 100 |
|
|
2018
Q3 | $1.39M | Buy |
12,905
+585
| +5% | +$58.5K | 0.25% | 110 |
|
|
2018
Q2 | $1.05M | Buy |
12,320
+86
| +0.7% | +$7.06K | 0.2% | 123 |
|
|
2018
Q1 | $947K | Buy |
12,234
+3,489
| +40% | +$281K | 0.12% | 164 |
|
|
2017
Q4 | $739K | Sell |
8,745
-53
| -0.6% | -$4.51K | 0.13% | 140 |
|
|
2017
Q3 | $753K | Sell |
8,798
-1,264
| -13% | -$104K | 0.14% | 135 |
|
|
2017
Q2 | $828K | Buy |
10,062
+493
| +5% | +$40.2K | 0.17% | 127 |
|
|
2017
Q1 | $804K | Buy |
9,569
+306
| +3% | +$24.5K | 0.24% | 107 |
|
|
2016
Q4 | $681K | Buy |
9,263
+729
| +9% | +$54.3K | 0.2% | 102 |
|
|
2016
Q3 | $685K | Hold |
8,534
| – | – | 0.2% | 108 |
|
|
2016
Q2 | $672K | Sell |
8,534
-650
| -7% | -$48.9K | 0.19% | 108 |
|
|
2016
Q1 | $661K | Sell |
9,184
-59
| -0.6% | -$4.46K | 0.19% | 107 |
|
|
2015
Q4 | $779K | Hold |
9,243
| – | – | 0.24% | 96 |
|
|
2015
Q3 | $774K | Sell |
9,243
-825
| -8% | -$69.6K | 0.25% | 97 |
|
|
2015
Q2 | $841K | Sell |
10,068
-100
| -1% | -$7.62K | 0.25% | 95 |
|
|
2015
Q1 | $739K | Sell |
10,168
-500
| -5% | -$35.6K | 0.22% | 102 |
|
|
2014
Q4 | $736K | Sell |
10,668
-350
| -3% | -$23.6K | 0.23% | 99 |
|
|
2014
Q3 | $715K | Buy |
11,018
+25
| +0.2% | +$1.58K | 0.24% | 97 |
|
|
2014
Q2 | $683K | Sell |
10,993
-77
| -0.7% | -$4.59K | 0.23% | 97 |
|
|
2014
Q1 | $652K | Sell |
11,070
-100
| -0.9% | -$5.58K | 0.22% | 96 |
|
|
2013
Q4 | $570K | Sell |
11,170
-1,845
| -14% | -$92.4K | 0.2% | 103 |
|
|
2013
Q3 | $655K | Buy |
13,015
+1,355
| +12% | +$70.9K | 0.25% | 92 |
|
|
2013
Q2 | $573K | Buy |
+11,660
| New | +$634K | 0.22% | 96 |
|
Other funds holding LLY
SC
Canandaigua National Bank & Trust's LLY Position: Q2 2026 in Review
Canandaigua National Bank & Trust opened a new position in Eli Lilly (LLY) in Q2 2026: 7,511 shares worth $9.01M. The stake represents 0.76% of the portfolio and ranks #28 among its holdings. This is a return to the name: Canandaigua National Bank & Trust previously reported a position in LLY as recently as Q4 2025.
Canandaigua National Bank & Trust first reported a position in LLY in Q2 2013 and has held it in 41 quarters since. The position peaked at $9.36M in Q4 2025. 2,247 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Canandaigua National Bank & Trust held 7,511 shares of Eli Lilly worth $9.01M as of Q2 2026.
- Eli Lilly was a new Canandaigua National Bank & Trust position in Q2 2026.
- Eli Lilly made up 0.76% of Canandaigua National Bank & Trust's portfolio in Q2 2026, its #28 holding.
- Canandaigua National Bank & Trust first reported a position in Eli Lilly in Q2 2013 and has held it in 41 quarters since.
- Canandaigua National Bank & Trust's Eli Lilly position peaked at $9.36M in Q4 2025.
- 2,247 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Canandaigua National Bank & Trust's 13F filing for Q2 2026, filed 7 Jul 2026.